The Interplay between Inflammation, Anti-Angiogenic Agents, and Immune Checkpoint Inhibitors: Perspectives for Renal Cell Cancer Treatment

Treatment options for metastatic renal cell carcinoma (RCC) have been expanding in the last years, from the consolidation of several anti-angiogenic agents to the approval of immune checkpoint inhibitors (ICIs). The rationale for the use of immunomodulating agents derived from the observation that R...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers (Basel)
Hauptverfasser: Brighi, Nicole, Farolfi, Alberto, Conteduca, Vincenza, Gurioli, Giorgia, Gargiulo, Stefania, Gallà, Valentina, Schepisi, Giuseppe, Lolli, Cristian, Casadei, Chiara, De Giorgi, Ugo
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2019
Schlagworte:
Review
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6966461/
https://ncbi.nlm.nih.gov/pubmed/31817109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11121935
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge